Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec‐7‐dependent and‐independent mechanisms

G Nicoll, T Avril, K Lock, K Furukawa… - European journal of …, 2003 - Wiley Online Library
Siglec‐7 is a sialic acid binding receptor with inhibitory potential, expressed on human NK
cells and monocytes. It has an unusual binding preference for α2, 8‐linked disialic acids …

Probing the cis interactions of the inhibitory receptor Siglec-7 with α2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific …

T Avril, SJ North, SM Haslam… - Journal of leukocyte …, 2006 - academic.oup.com
Abstract Siglec-7 is a CD33-related sialic acid-binding Ig-like lectin expressed strongly on
NK cells, where it can function as an inhibitory receptor. Its sialic acid-binding activity on NK …

Cross-presentation of disialoganglioside GD3 to natural killer T cells

DY Wu, NH Segal, S Sidobre, M Kronenberg… - The Journal of …, 2003 - rupress.org
GD3, a ganglioside expressed on human melanoma, can be recognized by the humoral
immune system. In this paper, we demonstrate that immunizing mice with the human …

[HTML][HTML] Discovery of a new sialic acid binding region that regulates Siglec-7

N Yamakawa, Y Yasuda, A Yoshimura, A Goshima… - Scientific reports, 2020 - nature.com
Siglec-7 is a human CD33-like siglec, and is localised predominantly on human natural
killer (NK) cells and monocytes. Siglec-7 is considered to function as an immunoreceptor in …

Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells

J Leòn, A Fernandez, C Mesa, M Clavel… - Cancer Immunology …, 2006 - Springer
Gangliosides have diverse biological functions including modulation of immune system
response. These molecules are differentially expressed on malignant cells compared with …

Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis

J Péguet-Navarro, M Sportouch, I Popa… - The Journal of …, 2003 - journals.aai.org
Gangliosides are ubiquitous membrane-associated glycosphingolipids, which are involved
in cell growth and differentiation. Most tumor cells synthesize and shed large amounts of …

Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor

J MUNDAY, S KERR, J NI, AL CORNISH… - Biochemical …, 2001 - portlandpress.com
Here we characterize Siglec-10 as a new member of the Siglec family of sialic acid-binding
Ig-like lectins. A full-length cDNA was isolated from a human spleen library and the …

[HTML][HTML] Siglec-7 undergoes a major conformational change when complexed with the α (2, 8)-disialylganglioside GT1b

H Attrill, A Imamura, RS Sharma, M Kiso… - Journal of Biological …, 2006 - ASBMB
The siglecs are a group of mammalian sialic acid binding receptors expressed
predominantly in the immune system. The CD33-related siglecs show complex recognition …

Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells

Y Kawasaki, A Ito, DA Withers, T Taima, N Kakoi… - …, 2010 - academic.oup.com
In renal cell carcinoma (RCC), the presence of higher gangliosides correlates with
systematic metastasis. Disialosyl globopentaosylceramide (DSGb5) was identified …

GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells

G Sa, T Das, C Moon, CM Hilston, PA Rayman, BI Rini… - Cancer research, 2009 - AACR
We previously elucidated an important role for gangliosides in renal cell carcinoma–
mediated T lymphocyte apoptosis, although the mechanism by which they mediated …